• Recherche translationnelle en santé,


    technologie pour la santé et recherche clinique

    https://tonic.inserm.fr/wp-content/uploads/2020/10/photoIQ_NB-150x150.jpg
     

    Isabelle QUELVEN

    MCU-PH

      Publications rédigées ou co-rédigées

    • > 61- Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging.

      Badier L, Quelven I.

      Pharmaceutics. 2024 Jun 30;16(7):882. doi: 10.3390/pharmaceutics16070882.
    • > 29- [18F]-Radiolabelled Nanoplatforms: A Critical Review of Their Intrinsic Characteristics, Radiolabelling Methods, and Purification Techniques.

      Deleuziere M, Benoist É, Quelven I, Gras E, Amiens C.

      Molecules. 2024 Mar 29;29(7):1537. doi: 10.3390/molecules29071537
    • > 69- Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma.

      Durand-Panteix S, Monteil J, Sage M, Garot A, Clavel M, Saidi A, Torgue J, Cogne M, Quelven I.

      Br J Cancer. 2021 Oct 20. doi: 10.1038/s41416-021-01585-6. Online ahead of print.